German Remedies Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 70.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 66.83 Cr
as on 24-10-2024
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 34.60 Cr
as on 24-10-2024
- Revenue 10.09%
(FY 2023)
- Profit -23.31%
(FY 2023)
- Ebitda -26.08%
(FY 2023)
- Net Worth 20.95%
(FY 2023)
- Total Assets 16.68%
(FY 2023)
About German Remedies Pharmaceuticals
The Corporate was formerly known as Acme Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 70.00 Cr and a paid-up capital of Rs 66.83 Cr.
The company has closed loans amounting to ₹34.60 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at German Remedies Pharmaceuticals Private Limited India are Arvind Bothra as CFO and Sanjay Gupta as Company Secretary. Bhavana Doshi, Jyotindra Gor, Rajib Baidya, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ2010PTC063425
- Company No.
063425
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 2010
- Date of AGM
02 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at German Remedies Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arvind Bothra | CFO | 17-May-2023 | Current |
| Sanjay Gupta | Company Secretary | 03-Jan-2020 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajib Baidya  | Director | 29-Mar-2018 | Current |
| Bhavana Doshi | Director | 12-Jun-2020 | Current |
| Jyotindra Gor | Director | 29-Mar-2018 | Current |
| Devanand Singh | Whole-Time Director | 03-Jan-2020 | Current |
| Chimanlal Patel | Director | 29-Mar-2018 | Current |
Financial of German Remedies Pharmaceuticals.
German Remedies Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.09% increase. The company also saw a substantial fall in profitability, with a 23.31% decrease in profit. The company's net worth Soared by an impressive increase of 20.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of German Remedies Pharmaceuticals?
In 2022, German Remedies Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zydus Healthcare LimitedActive 35 years 4 monthsBhavana Doshi, Arvind Bothra and 1 more are mutual person
Zydus Animal Health And Investments LimitedActive 6 years 7 monthsBhavana Doshi and Chimanlal Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 19 Nov 2014 | ₹2.10 Cr | Satisfied |
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 19 Nov 2014 | ₹8.90 Cr | Satisfied |
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 10 Nov 2014 | ₹23.60 Cr | Satisfied |
How Many Employees Work at German Remedies Pharmaceuticals?
Unlock and access historical data on people associated with German Remedies Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of German Remedies Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped German Remedies Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
